Synapsin Pharmaceuticals' Other Investors

Synapsin Pharmaceuticals raised a round of funding on , . Investors include USC Columbia Technology Incubator.

SYNAPSIN is developing therapeutic strategies for the treatmentand prevention ofneurodegenerative disorders such as Alzheimer's disease (AD),Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), a…

Articles about Synapsin Pharmaceuticals' Other Investors: